Slideshow

9 Key Facts About CVD in Rheumatoid Arthritis

Rheumatoid arthritis patients have an increased risk of developing cardiovascular disease, yet rheumatologists and primary care physicians who treat RA patients sometimes miss the signs and symptoms of CVD in their patients. Learn more in this slideshow.

Rheumatoid arthritis (RA) patients have an increased risk of developing cardiovascular disease (CVD), yet rheumatologists and primary care physicians who treat RA patients sometimes miss the signs and symptoms of CVD in their patients."The CV risk in patients with RA is not well recognized by practicing physicians, and better recognition and control of traditional risk factors in patients with RA is important," according to Sherine E. Gabriel, M.D., and colleagues writing in a review published in the American Heart Journal in October 2013. "Coordination of care among rheumatologists, cardiologists, and primary care physicians will be needed for optimal management of cardiovascular risk in patients with rheumatoid arthritis."Dr. Gabriel and colleagues outlined factors associated with both rheumatoid arthritis and cardiovascular disease. In this slideshow, we highlight some of their findings.REFERENCE:  Cynthia S.Crowson MS, Katherine P.Liao MD MPH, John M.Davis III MD, et al "Rheumatoid arthritis and cardiovascular disease," American Heart Journal. October 2013. DOI:https://doi.org/10.1016/j.ahj.2013.07.010 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.